Skip to main content

Advertisement

SpringerLink
Log in

Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Efficient gene delivery into keratinocytes is a prerequisite for successful skin gene therapy. Vectors based on recombinant adeno-associated virus type 2 (rAAV-2) offer several promising features that make them attractive for cutaneous applications. However, highly efficient gene delivery may be hampered by different cellular factors, including lack of viral receptors, impairment of cytoplasmic trafficking or limitations in viral second-strand synthesis. This study was undertaken to find factors that influence rAAV-2-mediated in vitro gene transfer into human keratinocytes and, consequently, ways to optimize gene delivery. Transduction experiments using rAAV-2 vectors expressing green fluorescent protein (GFP) demonstrated that impaired cellular trafficking of vector particles and high levels of autophosphorylation at epidermal growth factor receptor tyrosine kinase (EGF-R TK) have a negative influence on gene transfer into keratinocytes. Treatment of keratinocytes with proteasome inhibitor MG132 resulted in a transient augmentation of GFP expression in up to 37% of cells. Treatment with EGF-R TK inhibitors (quinazoline type) enhanced transgene expression in 10–14.5% of the cells. Gene expression was stable for more than 10 weeks and persisted until proliferative senescence occurred. This stable gene expression allows speculation that keratinocyte stem cells have initially been transduced. These findings might have relevance for the use of rAAV-2 vectors in skin gene therapy: transient enhancement of rAAV-2 transduction with proteasome inhibitors might be useful for genetic promotion of wound healing or skin-directed vaccination. Treatment with quinazolines may increase rAAV-2 transduction of keratinocyte stem cells, which is important for gene therapy approaches to inherited diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

rAAV-2:

Recombinant adeno-associated virus type 2

EGF-R TK:

Epidermal growth factor receptor tyrosine kinase

GFP:

Green fluorescent protein

p.t.:

Post transduction

References

  1. Büning H, Braun-Falco M, Hallek K (2004) Progress in the use of recombinant adeno-associated virus vectors for gene therapy. Cells Tissues Organs 177:139–150

    Google Scholar 

  2. Carter PJ, Samulski RJ (2000) Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 6:17–27

    Google Scholar 

  3. Del Rio M, Gache Y, Jorcano JL, Meneguzzi G, Larcher F (2004) Current approaches and perspectives in human keratinocyte-based gene therapies. Gene Ther 11:S57–S63

    Google Scholar 

  4. Braun-Falco M (2002) Gene therapy concepts for promoting wound healing. Hautarzt 53:238–243

    Google Scholar 

  5. Khavari PA, Rollman O, Vahlquist A (2002) Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252:1–10

    Google Scholar 

  6. Deodato B, Arsic N, Zentilin L, Galeano M, Santoro D, Torre V, Altavilla D, Valdemibri E, Bussolino F, Squadrito F, Giacca M (2002) Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 9:777–785

    Google Scholar 

  7. Galeano M, Deodato B, Altavilla D, Squadrito G, Seminara P, Marini H, Stagno d’Alcontres F, Colonna M, Calo M, Lo Cascio P, Torre V, Giacca M, Venuti FS, Squadrito F (2003) Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit Care Med 31:1017–1025

    Google Scholar 

  8. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M, Squadrito F (2003) Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 46:546–555

    Google Scholar 

  9. Hengge UR, Mirmohammadsadegh A (2000) Adeno-associated virus expresses transgenes in hair follicles and epidermis. Mol Ther 2:188–194

    Google Scholar 

  10. Maass G, Bogedain C, Scheer U, Michl D, Horer M, Braun-Falco M, Volkenandt M, Schadendorf D, Wendtner CM, Winnacker EL, Kotin RM, Hallek M (1998) Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cells. Hum Gene Ther 9:1049–1059

    Google Scholar 

  11. Braun-Falco M, Doenecke A, Smola H, Hallek M (1999) Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors. Gene Ther 6:432–441

    Google Scholar 

  12. Xiao X, Li J, Samulski RJ (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224–2232

    CAS  PubMed  Google Scholar 

  13. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Cesnut K, Summerford C, Samulski RJ, Muzyczka N (1999) Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6:973–985

    Google Scholar 

  14. Ding W, Yan Z, Zak R, Saavedra M, Rodman DM, Engelhardt JF (2003) Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J Virol 77:7361–7366

    Google Scholar 

  15. Douar AM, Poulard K, Stockholm D, Danos O (2001) Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J Virol 75:1824–1833

    Google Scholar 

  16. Duan D, Yue Y, Yan Z, Yang J, Engelhardt JF (2000) Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus. J Clin Invest 105:1573–1587

    Google Scholar 

  17. Nicklin SA, Büning H, Dishart KL, de Alwis M, Girod A, Hacker U, Thrasher AJ, Ali RR, Hallek M, Baker AH (2001) Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. Mol Ther 4:174–181

    Google Scholar 

  18. Yan Z, Zak R, Luxton GW, Ritchie TC, Bantel-Schaal U, Engelhardt JF (2002) Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J Virol 76:2043–2053

    Google Scholar 

  19. Mah C, Qing KY, Khuntirat B, Ponnazhagan S, Wang X-S, Kube DM, Yoder MC, Srivastava A (1998) Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J Virol 72:9835–9843

    Google Scholar 

  20. Peus D, Hamacher L, Pittelkow MR (1997) EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J Invest Dermatol 109:751–756

    Google Scholar 

  21. Powell TJ, Ben-Bassat H, Klein BY, Chen H, Shenoy N, McCollough J, Narog B, Gazit A, Harzstark Z, Chaouat M, Levitzki R, Tang C, McMahon J, Shawver L, Levitzki A (1999) Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors. Br J Dermatol 141:802–810

    Google Scholar 

  22. Rodeck U, Jost M, Kari C, Shih D-T, Lavker RM, Ewert DL, Jensen PJ (1997) EGF-R dependent regulation of keratinocyte survival. J Cell Sci 110:113–121

    Google Scholar 

  23. During MJ, Samulski RJ, Elsworth JD, Kaplitt MG, Leone P, Xiao X, Li J, Freese A, Taylor JR, Roth RH, Sladek JR Jr, O’Malley KL, Redmond DE Jr (1998) In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther 5:820–827

    Article  CAS  PubMed  Google Scholar 

  24. Guy J, Qi X, Muzyczka N, Hauswirth WW (1999) Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol 117:929–937

    Google Scholar 

  25. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA (1999) Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5:56–63

    Article  CAS  PubMed  Google Scholar 

  26. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA (1997) Persistent and therapeutic concentration of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16:270–276

    Google Scholar 

  27. Sangioglu S, Monick MM, Luleci G, Hunninghake GW, Engelhardt JF (2001) Rate limiting steps of AAV transduction and implications for human gene therapy. Curr Gene Ther 1:137–147

    Google Scholar 

  28. Xiao X, Li J, Samulski RJ (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70:8098–8108

    Google Scholar 

  29. Ponnazhagan S, Wang X-S, Woody MJ, Luo F, Kang LY, Nallari ML, Munshi NC, Zhou SZ, Srivastava A (1996) Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukemia cells are non-permissive for AAV infection. J Gen Virol 77:1111–1122

    Google Scholar 

  30. Ponnazhagan S, Mukherjee P, Wang X-S, Kurpad C, Qing K, Kube D, Mah C, Yoder M, Srour EF, Srivastava A (1997) Adeno-associated virus 2-mediated transduction of primary human bone marrow derived CD34+ hematopoietic progenitor cells: donor variation and correlation of expression with cellular differentiation. J Virol 71:8262–8267

    Google Scholar 

  31. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A (1999) Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5:71–77

    Google Scholar 

  32. Summerford C, Samulski RJ (1998) Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438–1445

    Google Scholar 

  33. Summerford C, Bartlett JS, Samulski RJ (1999) Alpha v beta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 5:78–82

    Google Scholar 

  34. Hansen J, Qing K, Kwon HJ, Mah C, Srivastava A (2000) Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J Virol 74:992–996

    Google Scholar 

  35. Ferrari FK, Samulski T, Shenk T, Samulski RJ (1996) Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 70:3227–3234

    Google Scholar 

  36. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM (1996) Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 70:520–532

    Google Scholar 

  37. Büning H, Ried MU, Gerner FM, Huttner NA, Enssle J, Hallek M (2003) Receptor targeting of adeno-associated virus vectors. Gene Ther 10:1142–1151

    Google Scholar 

  38. Alexander IE, Russell DW, Miller AD (1994) DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68:8282–8287

    Google Scholar 

  39. Russel DW, Alexander IE, Miller AD (1995) DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci U S A 92:5719–5723

    Google Scholar 

  40. Zabner J, Seiler M, Walters R, Kotin RM, Fulgeras W, Davidson BL, Chiorini JA (2000) Adeno-associated virus type 5 (AAV 5) but not AAV 2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol 74:3852–3858

    Google Scholar 

  41. Kim JP, Zhang K, Chen JD, Kramer RH, Woodley DT (1994) Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. J Biol Chem 269:26926–26932

    Google Scholar 

  42. Lundquist K, Schmidtchen A (2001) Immunohistochemical studies on proteoglycan expression in normal skin and chronic ulcers. Br J Dermatol 144:254–259

    Google Scholar 

  43. Marchese C, Sorice M, De Stefano C, Frati L, Torrisi MR (1997) Modulation of keratinocyte growth factor receptor expression in human cultured keratinocytes. Cell Growth Differ 8:989–997

    Google Scholar 

  44. Pittelkow MR, Cook P, Shipley G, Derynck R, Coffey RI (1993) Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ 4:513–521

    Google Scholar 

  45. Qing KY, Wang X-S, Kube DM, Ponnazhagan S, Bajpai A, Srivastava A (1997) Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci U S A 94:10879–10884

    Google Scholar 

  46. Qing KY, Khuntrirat B, Mah C, Kube DM, Wang X-S, Ponnazhagan S, Zhou S, Dwarki VJ, Yoder MC, Srivastava A (1998) Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J Virol 72:1593–1599

    Google Scholar 

  47. Adams J (2002) Development of the proteasome inhibitor PS-341. Oncologist 7:9–16

    Google Scholar 

  48. Baselga J (2002) Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7 [Suppl 4]:2–8

    Google Scholar 

  49. Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob SW, Fendrich G, Liebetanz J, Mestan J, O’Reilly T, Traxler P, Chaudhuri B, Fretz H, Zimmermann J, Meyer T, Caravatti G, Furet P, Manley PW (2002) Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol Ther 93:79–98

    Google Scholar 

  50. Bramson JL, Dayball K, Evelegh C, Wan YH, Page D, Smith A (2003) Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther 10:251–260

    Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the German Research Council/Deutsche Forschungsgemeinschaft (BR2004/1-1) and the “Clinical research funds-KKF”, Klinikum Rechts der Isar, Technical University Munich. The work presented in this paper was performed as part of the doctoral thesis of A.E.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Division of Environmental Dermatology and Allergy, National Research Center for Environment & Health, Technische Universität München and GSF, Biedersteinerstr. 29, 80802, Munich, Germany

    Markus Braun-Falco, Angelika Eisenried & Johannes Ring

  2. Genzentrum, Ludwig-Maximilians-Universität München, Munich, Germany

    Hildegard Büning

Authors
  1. Markus Braun-Falco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelika Eisenried
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hildegard Büning
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Johannes Ring
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Markus Braun-Falco.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braun-Falco, M., Eisenried, A., Büning, H. et al. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase. Arch Dermatol Res 296, 528–535 (2005). https://doi.org/10.1007/s00403-005-0547-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-005-0547-y

Keywords

Search

Navigation